Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...
02 Dezembro 2020 - 10:19AM
Edgar (US Regulatory)
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b)
OF THE SECURITIES EXCHANGE ACT OF 1934.
| |
|
Commission File Number
000-55275 |
|
| Issuer: | Neurotrope, Inc. |
| Exchange: | The Nasdaq Stock Market LLC |
|
(Exact name of Issuer as specified in its charter, and name of
Exchange where security is listed and/or registered)
|
|
| Address: | 205 East 42nd Street
New York,
NEW YORK
10017 |
| Telephone number: | 973-242-0005 |
|
(Address, including zip code, and telephone number, including area code, of Issuer's
principal executive offices)
|
|
| Common Stock |
|
(Description of class of securities)
|
|
|
Please place an X in the box to designate the rule provision relied upon to strike
the class of securities from listing and registration:
|
| o 17 CFR 240.12d2-2(a)(1) |
| o 17 CFR 240.12d2-2(a)(2) |
| x 17 CFR 240.12d2-2(a)(3) |
| o 17 CFR 240.12d2-2(a)(4) |
| o
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.
1 |
| o
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
|
|
|
Pursuant to the requirements for the Securities Exchange Act of 1934,
The Nasdaq Stock Market LLC
certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
|
|
| 2020-12-02 | By | Tara Petta | | Director |
|
Date
| | Name | | Title |
|
| 1 |
Form 25 and attached Notice will be considered compliance with the provisions of
17 CFR 240.19d-1 as applicable. See General Instructions.
NextTrip (NASDAQ:NTRP) Gráfico Histórico do Ativo De Out 2024 até Nov 2024
NextTrip (NASDAQ:NTRP) Gráfico Histórico do Ativo De Nov 2023 até Nov 2024
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Terça, 12 de Novembro de 2024 (2 semanas atrás) • Edgar (US Regulatory) |
Form 8-K - Current report
Terça, 12 de Novembro de 2024 (2 semanas atrás) • Edgar (US Regulatory) |
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Terça, 15 de Outubro de 2024 (1 mês atrás) • Edgar (US Regulatory) |
Form 8-K - Current report
Terça, 8 de Outubro de 2024 (2 meses atrás) • Edgar (US Regulatory) |
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Terça, 1 de Outubro de 2024 (2 meses atrás) • Edgar (US Regulatory) |
Form 8-K - Current report
Quarta, 25 de Setembro de 2024 (2 meses atrás) • Edgar (US Regulatory) |
Form 8-K - Current report
Sexta, 20 de Setembro de 2024 (2 meses atrás) • Edgar (US Regulatory) |
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Segunda, 16 de Setembro de 2024 (2 meses atrás) • Edgar (US Regulatory) |
Form 8-K - Current report
Sexta, 19 de Julho de 2024 (4 meses atrás) • Edgar (US Regulatory) |
Form 8-K - Current report
Quinta, 18 de Julho de 2024 (4 meses atrás) • Edgar (US Regulatory) |
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Sexta, 31 de Maio de 2024 (6 meses atrás) • Edgar (US Regulatory) |
Mais Notícias de Neurotrope, Inc.
Parece que você não está logado. Clique no botão abaixo para se logar e ver seu histórico recente.
|
| Cotações em Tempo Real | Book de Ofertas |
|---|
| | |
|---|
| | |
|---|
| | |
|---|
*Ao longo de 3 anos $ 881.64 apenas $ 352.65